Latest News

Safety Concerns Arise Amid Andexanet’s Superior Performance in Hematoma Expansion Resolution
Safety Concerns Arise Amid Andexanet’s Superior Performance in Hematoma Expansion Resolution

May 27th 2024

Overall, a significantly greater amount of patients on Andexanet had hematoma volume expansion of 35% or less; however, these patients had greater risk of thrombolytic events and lower modified Rankin scale scores at 30 days.

This Week on NeurologyLive® — May 27 2024
This Week on NeurologyLive® — May 27 2024

May 27th 2024

Abstracts for the 2024 CMSC Annual Meeting Are Now Live!
Abstracts for the 2024 CMSC Annual Meeting Are Now Live!

May 26th 2024

The 2024 CMSC Annual Meeting Abstract Guide
The 2024 CMSC Annual Meeting Abstract Guide

May 26th 2024

NeurologyLive® Brain Games: May 26, 2024
NeurologyLive® Brain Games: May 26, 2024

May 26th 2024

Coverage of the 2024 American Academy of Neurology Annual Meeting

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of the AAN Annual Meeting.

AAN 2024

Conference Coverage

View All
Post-AAN Perspectives: Recapping Major Areas of Growth in Neurology
Post-AAN Perspectives: Recapping Major Areas of Growth in Neurology

May 23rd 2024

NeuroVoices: Katherine Peters, PhD, on Vorasidenib’s Impact on Quality of Life, Neurocognition, and Seizures in the Treatment of Gliomas
NeuroVoices: Katherine Peters, PhD, on Vorasidenib’s Impact on Quality of Life, Neurocognition, and Seizures in the Treatment of Gliomas

May 22nd 2024

Frederic Schaper, MD, PhD  (Credit: Harvard Catalyst)
Exploring the Association Between Brain Lesions and Takotsubo Syndrome

May 21st 2024

Susan W. Broner, MD  (Credit: Weill Cornell Medicine)
Essentials for Treating Headache as a General Neurologist

May 19th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.